Review





Similar Products

ultrafast dce mri  (Philips Healthcare)
86
Philips Healthcare ultrafast dce mri
Ultrafast Dce Mri, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pm41823605-60-0-7?v=Philips+Healthcare
Average 86 stars, based on 1 article reviews
ultrafast dce mri - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
dce mri measurement  (Philips Healthcare)
86
Philips Healthcare dce mri measurement
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri Measurement, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pmc12913062-162-0-8?v=Philips+Healthcare
Average 86 stars, based on 1 article reviews
dce mri measurement - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
dce mri  (Bruker Corporation)
97
Bruker Corporation dce mri
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pm41498583-406-21-25?v=Bruker+Corporation
Average 97 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
dce mri  (Hirschmann)
86
Hirschmann dce mri
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri, supplied by Hirschmann, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/10__3390_slash_diagnostics16010136-103-20-0?v=Hirschmann
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
dce mri  (Jiangsu Hengrui Medicine)
86
Jiangsu Hengrui Medicine dce mri
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pmc12789915-71-1-8?v=Jiangsu+Hengrui+Medicine
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
dce mri  (Bayer Schering Pharma)
86
Bayer Schering Pharma dce mri
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dce Mri, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pm41135295-65-1-4?v=Bayer+Schering+Pharma
Average 86 stars, based on 1 article reviews
dce mri - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
dedicated dce mri software  (Siemens Healthineers)
86
Siemens Healthineers dedicated dce mri software
Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
Dedicated Dce Mri Software, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dce-mri/pmc12346550-219-16-21?v=Siemens+Healthineers
Average 86 stars, based on 1 article reviews
dedicated dce mri software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques: Diffusion-based Assay

Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques:

Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

Journal: Frontiers in Oncology

Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

doi: 10.3389/fonc.2026.1714620

Figure Lengend Snippet: Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

Techniques: Diagnostic Assay, Comparison